{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:20:12Z","timestamp":1791404412945,"version":"4.3.3"},"reference-count":261,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","award":["3\/1\/3\/PDF(24)\/2021-HRD-4"],"award-info":[{"award-number":["3\/1\/3\/PDF(24)\/2021-HRD-4"]}],"id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"India Ministry of Science &amp; Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["6242- P24\/RGCB1PMD\/ DBT \/ARJN\/2015"],"award-info":[{"award-number":["6242- P24\/RGCB1PMD\/ DBT \/ARJN\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/9\/1327\/2020-Nut"],"award-info":[{"award-number":["5\/9\/1327\/2020-Nut"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/9\/1108\/2013-Nut"],"award-info":[{"award-number":["5\/9\/1108\/2013-Nut"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024390","name":"National Institute of Nutrition","doi-asserted-by":"publisher","award":["15-BS05"],"award-info":[{"award-number":["15-BS05"]}],"id":[{"id":"10.13039\/501100024390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.gendis.2022.12.013","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T22:59:47Z","timestamp":1674169187000},"page":"148-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance"],"prefix":"10.1016","volume":"11","author":[{"given":"Divya","family":"Ajmeera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajanna","family":"Ajumeera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib1","first-page":"209","article-title":"Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmhg.2014.09.003","article-title":"Cancer: some genetic considerations","volume":"16","author":"Salem","year":"2015","journal-title":"Egypt J Med Hum Genet"},{"key":"10.1016\/j.gendis.2022.12.013_bib3","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.canep.2015.03.017","article-title":"European Code against Cancer 4th Edition: environment, occupation and cancer","volume":"39","author":"Espina","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"7","key":"10.1016\/j.gendis.2022.12.013_bib4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jnutbio.2013.02.009","article-title":"Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context","volume":"24","author":"Ruiz-N\u00fa\u00f1ez","year":"2013","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.gendis.2022.12.013_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1475-2891-3-19","article-title":"Nutrition and cancer: a review of the evidence for an anti-cancer diet","volume":"3","author":"Donaldson","year":"2004","journal-title":"Nutr J"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/bjc.2014.598","article-title":"Diet, exercise, obesity, smoking and alcohol consumption in cancer survivors and the general population: a comparative study of 16 282 individuals","volume":"112","author":"Wang","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gendis.2022.12.013_bib7","author":"Debela","year":"20219"},{"issue":"7","key":"10.1016\/j.gendis.2022.12.013_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib9","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3390\/cancers3033279","article-title":"Assessment of the evolution of cancer treatment therapies","volume":"3","author":"Arruebo","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2022.12.013_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2018.00245","article-title":"Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.gendis.2022.12.013_bib11","series-title":"Cancer chemotherapy. In: StatPearls [Internet]. Treasure Island (FL)","author":"Amjad","year":"2022"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/exd.13846","article-title":"How chemotherapy and radiotherapy damage the tissue: comparative biology lessons from feather and hair models","volume":"28","author":"Gao","year":"2019","journal-title":"Exp Dermatol"},{"issue":"7","key":"10.1016\/j.gendis.2022.12.013_bib13","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","article-title":"Surgery for cancer: a trigger for metastases","volume":"77","author":"Tohme","year":"2017","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int J Med Sci"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.20892\/j.issn.2095-3941.2016.0068","article-title":"Recent advances of sonodynamic therapy in cancer treatment","volume":"13","author":"Wan","year":"2016","journal-title":"Cancer Biol Med"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib16","first-page":"250","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.gendis.2022.12.013_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3332\/ecancer.2019.961","article-title":"Innovative approaches for cancer treatment: current perspectives and new challenges","volume":"13","author":"Pucci","year":"2019","journal-title":"Ecancermedicalscience"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.cgt.7700537","article-title":"Oncolytic Herpes simplex virus vectors for cancer virotherapy","volume":"9","author":"Varghese","year":"2002","journal-title":"Cancer Gene Ther"},{"issue":"7","key":"10.1016\/j.gendis.2022.12.013_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2146\/ajhp110608","article-title":"Brentuximab vedotin: an anti-CD30 antibody-drug conjugate","volume":"70","author":"Bradley","year":"2013","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cancers10120471","article-title":"Chemoresistance and the self-maintaining tumor microenvironment","volume":"10","author":"Yeldag","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2022.12.013_bib21","article-title":"Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cell Int"},{"issue":"7","key":"10.1016\/j.gendis.2022.12.013_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4252\/wjsc.v11.i7.398","article-title":"Targeting cancer stem cells in drug discovery: current state and future perspectives","volume":"11","author":"Du","year":"2019","journal-title":"World J Stem Cell"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib23","first-page":"151","article-title":"The importance of clinical trials in drug development","volume":"8","author":"Akhondzadeh","year":"2016","journal-title":"Avicenna J Med Biotechnol (AJMB)"},{"key":"10.1016\/j.gendis.2022.12.013_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.659963","article-title":"Innovative approaches in the battle against cancer recurrence: novel strategies to combat dormant disseminated tumor cells","volume":"11","author":"Sauer","year":"2021","journal-title":"Front Oncol"},{"issue":"13","key":"10.1016\/j.gendis.2022.12.013_bib25","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.18632\/oncotarget.4037","article-title":"EMT, CTCs and CSCs in tumor relapse and drug-resistance","volume":"6","author":"Mitra","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib26","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","article-title":"Cancer stem cells","volume":"44","author":"Yu","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.gendis.2022.12.013_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semcancer.2017.03.003","article-title":"The challenge of targeting cancer stem cells to halt metastasis","volume":"44","author":"Agliano","year":"2017","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2022.12.013_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.621556","article-title":"Editorial: modulation of human immune parameters by anticancer therapies","volume":"11","author":"Sack","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.gendis.2022.12.013_bib30","doi-asserted-by":"crossref","first-page":"a003236","DOI":"10.1101\/cshperspect.a003236","article-title":"Oncogenes and tumor suppressor genes","volume":"2","author":"Lee","year":"2010","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis","volume":"2","author":"Rivlin","year":"2011","journal-title":"Genes Cancer"},{"issue":"Suppl 5","key":"10.1016\/j.gendis.2022.12.013_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1289\/ehp.93101s515","article-title":"Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?","volume":"101","author":"Sell","year":"1993","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.gendis.2022.12.013_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.gendis.2022.12.013_bib34","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","article-title":"Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies","volume":"11","author":"Walcher","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1134\/S1990750817010036","article-title":"Cancer stem cell molecular markers verified in vivo","volume":"11","author":"Kim","year":"2017","journal-title":"Biochem Moscow Suppl Ser B"},{"key":"10.1016\/j.gendis.2022.12.013_bib36","article-title":"Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy","author":"Bao","year":"201314","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.gendis.2022.12.013_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.669250","article-title":"Reporters of cancer stem cells as a tool for drug discovery","volume":"11","author":"Mohan","year":"2021","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/jcb.22350","article-title":"Cancer stem cells: cell culture, markers, and targets for new therapies","volume":"108","author":"Gilbert","year":"2009","journal-title":"J Cell Biochem"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib39","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1172\/JCI66024","article-title":"Cancer stem cells in the development of liver cancer","volume":"123","author":"Yamashita","year":"2013","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.gendis.2022.12.013_bib40","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.ejca.2006.01.037","article-title":"Prostate cancer stem cells","volume":"42","author":"Collins","year":"2006","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3892\/mco.2012.29","article-title":"Cancer stem cell-like characteristics of a CD133+ subpopulation in the J82 human bladder cancer cell line","volume":"1","author":"Huang","year":"2013","journal-title":"Mol Clin Oncol"},{"issue":"26","key":"10.1016\/j.gendis.2022.12.013_bib42","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0704271104","article-title":"CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia","volume":"104","author":"Hosen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2009.04.018","article-title":"Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells","volume":"5","author":"Jin","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"7176","key":"10.1016\/j.gendis.2022.12.013_bib44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature06489","article-title":"Identification of cells initiating human melanomas","volume":"451","author":"Schatton","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2022.12.013_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1475-2867-13-78","article-title":"Functional features of cancer stem cells in melanoma cell lines","volume":"13","author":"Zimmerer","year":"2013","journal-title":"Cancer Cell Int"},{"issue":"30","key":"10.1016\/j.gendis.2022.12.013_bib46","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness","volume":"103","author":"Szotek","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.gendis.2022.12.013_bib47","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res"},{"issue":"25","key":"10.1016\/j.gendis.2022.12.013_bib48","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1200\/JCO.2009.27.5388","article-title":"Targeting breast cancer stem cells","volume":"28","author":"Liu","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.gendis.2022.12.013_bib49","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1053\/j.gastro.2009.12.063","article-title":"Colon cancer stem cells: promise of targeted therapy","volume":"138","author":"Todaro","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib50","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/stem.30","article-title":"Identification of gastric cancer stem cells using the cell surface marker CD44","volume":"27","author":"Takaishi","year":"2009","journal-title":"Stem Cell"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib51","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10120-012-0140-y","article-title":"Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer","volume":"15","author":"Jiang","year":"2012","journal-title":"Gastric Cancer"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib52","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/0022034511423393","article-title":"Head and neck cancer stem cells","volume":"91","author":"Krishnamurthy","year":"2012","journal-title":"J Dent Res"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00018-013-1386-1","article-title":"Asymmetric cell division of stem and progenitor cells during homeostasis and cancer","volume":"71","author":"G\u00f3mez-L\u00f3pez","year":"2014","journal-title":"Cell Mol Life Sci"},{"issue":"37","key":"10.1016\/j.gendis.2022.12.013_bib54","doi-asserted-by":"crossref","first-page":"39550","DOI":"10.18632\/oncotarget.6098","article-title":"Differentiation and transdifferentiation potentials of cancer stem cells","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.gendis.2022.12.013_bib55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.gendis.2022.12.013_bib56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fgene.2015.00157","article-title":"DNA repair mechanisms in cancer development and therapy","volume":"6","author":"Torgovnick","year":"2015","journal-title":"Front Genet"},{"issue":"1 Suppl 1","key":"10.1016\/j.gendis.2022.12.013_bib57","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/MD.0000000000004766","article-title":"Cancer stem cells: role in tumor growth, recurrence, metastasis, and treatment resistance","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pharmthera.2013.01.014","article-title":"Cancer stem cells and their role in metastasis","volume":"138","author":"Shiozawa","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.gendis.2022.12.013_bib59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.critrevonc.2015.12.005","article-title":"The Wnt signaling pathway in cancer","volume":"99","author":"Duchartre","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20091866","article-title":"Wnt signalling and the control of cellular metabolism","volume":"427","author":"Sethi","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.gendis.2022.12.013_bib61","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.3389\/fimmu.2019.02872","article-title":"Wnt signaling and its significance within the tumor microenvironment: novel therapeutic insights","volume":"10","author":"Patel","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/labinvest.2015.144","article-title":"The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies","volume":"96","author":"Yang","year":"2016","journal-title":"Lab Invest"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib63","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007880","article-title":"Frizzled and LRP5\/6 receptors for Wnt\/\u03b2-catenin signaling","volume":"4","author":"MacDonald","year":"2012","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"14","key":"10.1016\/j.gendis.2022.12.013_bib64","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1158\/1078-0432.CCR-06-2316","article-title":"WNT signaling pathway and stem cell signaling network","volume":"13","author":"Katoh","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib65","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3892\/ijo.2017.4129","article-title":"Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)","volume":"51","author":"Katoh","year":"2017","journal-title":"Int J Oncol"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib66","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/carcin\/bgp236","article-title":"Role of Notch signaling in colorectal cancer","volume":"30","author":"Qiao","year":"2009","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.gendis.2022.12.013_bib67","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1634\/stemcells.2005-0661","article-title":"Concise review: Notch signaling in stem cell systems","volume":"24","author":"Chiba","year":"2006","journal-title":"Stem Cell"},{"issue":"16","key":"10.1016\/j.gendis.2022.12.013_bib68","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2013-08-355818","article-title":"Notch signaling: switching an oncogene to a tumor suppressor","volume":"123","author":"Lobry","year":"2014","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.gendis.2022.12.013_bib69","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","article-title":"Hedgehog signaling in animal development: paradigms and principles","volume":"15","author":"Ingham","year":"2001","journal-title":"Genes Dev"},{"issue":"36","key":"10.1016\/j.gendis.2022.12.013_bib70","doi-asserted-by":"crossref","first-page":"60684","DOI":"10.18632\/oncotarget.19527","article-title":"The Hedgehog-GLI pathway in embryonic development and cancer: implications for pulmonary oncology therapy","volume":"8","author":"Armas-L\u00f3pez","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gendis.2022.12.013_bib71","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2148-9-28","article-title":"Emergence, development and diversification of the TGF-beta signalling pathway within the animal kingdom","volume":"9","author":"Huminiecki","year":"2009","journal-title":"BMC Evol Biol"},{"issue":"15","key":"10.1016\/j.gendis.2022.12.013_bib72","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.jmb.2019.05.022","article-title":"Molecular engineering of the TGF-\u03b2 signaling pathway","volume":"431","author":"Zi","year":"2019","journal-title":"J Mol Biol"},{"key":"10.1016\/j.gendis.2022.12.013_bib73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-3701-2-9","article-title":"Regulation of TGF-\u03b2 receptor activity","volume":"2","author":"Huang","year":"2012","journal-title":"Cell Biosci"},{"issue":"10","key":"10.1016\/j.gendis.2022.12.013_bib74","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","article-title":"Transforming growth factor-\u03b2 (TGF-\u03b2) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway","volume":"292","author":"Tang","year":"2017","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.gendis.2022.12.013_bib75","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1039\/C7MD00067G","article-title":"Imidazoles as potential anticancer agents","volume":"8","author":"Ali","year":"2017","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.gendis.2022.12.013_bib76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1200\/JCO.2005.02.120","article-title":"Tumoral drug metabolism: overview and its implications for cancer therapy","volume":"23","author":"Michael","year":"2005","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.gendis.2022.12.013_bib77","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1124\/dmd.107.015354","article-title":"Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17","volume":"35","author":"Shen","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib78","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis","volume":"2","author":"Rivlin","year":"2011","journal-title":"Genes Cancer"},{"issue":"7","key":"10.1016\/j.gendis.2022.12.013_bib79","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nm0796-811","article-title":"Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients","volume":"2","author":"Aas","year":"1996","journal-title":"Nat Med"},{"issue":"5411","key":"10.1016\/j.gendis.2022.12.013_bib80","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.284.5411.156","article-title":"Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition","volume":"284","author":"Soengas","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib81","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.chembiol.2013.04.007","article-title":"DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology","volume":"20","author":"Cheung-Ong","year":"2013","journal-title":"Chem Biol"},{"key":"10.1016\/j.gendis.2022.12.013_bib82","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphar.2020.00343","article-title":"The drug-resistance mechanisms of five platinum-based antitumor agents","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.gendis.2022.12.013_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012564","article-title":"Cancer cells acquire mitotic drug resistance properties through beta I-tubulin mutations and alterations in the expression of beta-tubulin isotypes","volume":"5","author":"Cheung","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.gendis.2022.12.013_bib84","first-page":"95","article-title":"Drug Resistance in Cancer Cells","author":"Mehta","year":"2009"},{"issue":"11","key":"10.1016\/j.gendis.2022.12.013_bib85","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.gendis.2022.12.013_bib86","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib87","first-page":"314","article-title":"Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer","volume":"57","author":"Koivisto","year":"1997","journal-title":"Cancer Res"},{"issue":"5536","key":"10.1016\/j.gendis.2022.12.013_bib88","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.293.5536.1793","article-title":"Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters","volume":"293","author":"Chang","year":"2001","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib89","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1517\/17425250903228834","article-title":"ABCG2:the key to chemoresistance in cancer stem cells?","volume":"5","author":"An","year":"2009","journal-title":"Expet Opin Drug Metabol Toxicol"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5732\/cjc.011.10320","article-title":"Breast cancer resistance protein (BCRP\/ABCG2):its role in multidrug resistance and regulation of its gene expression","volume":"31","author":"Nakanishi","year":"2012","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.gendis.2022.12.013_bib91","doi-asserted-by":"crossref","first-page":"6","DOI":"10.20517\/cdr.2018.02","article-title":"How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?","volume":"1","author":"Jaramillo","year":"2018","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.gendis.2022.12.013_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.629266","article-title":"DNA repair pathways in cancer therapy and resistance","volume":"11","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.gendis.2022.12.013_bib93","article-title":"Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition","volume":"6","author":"Huang","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10495-007-0154-9","article-title":"Apoptosis and autophagy: regulatory connections between two supposedly different processes","volume":"13","author":"Thorburn","year":"2008","journal-title":"Apoptosis"},{"issue":"5381","key":"10.1016\/j.gendis.2022.12.013_bib95","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","article-title":"Caspases: enemies within","volume":"281","author":"Thomberry","year":"1998","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.gendis.2022.12.013_bib96","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.cdd.4400601","article-title":"Serial killers: ordering caspase activation events in apoptosis","volume":"6","author":"Slee","year":"1999","journal-title":"Cell Death Differ"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib97","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1089\/ars.2010.3445","article-title":"Apoptosis-inducing factor: structure, function, and redox regulation","volume":"14","author":"Sevrioukova","year":"2011","journal-title":"Antioxidants Redox Signal"},{"issue":"9","key":"10.1016\/j.gendis.2022.12.013_bib98","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.gendis.2022.12.013_bib99","article-title":"Role of the crosstalk between autophagy and apoptosis in cancer","volume":"2013","author":"Su","year":"2013","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.gendis.2022.12.013_bib100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/1947601910393957","article-title":"DNA methylation: superior or subordinate in the epigenetic hierarchy?","volume":"2","author":"Jin","year":"2011","journal-title":"Genes Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib101","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.molcel.2009.04.001","article-title":"Epigenetic silencing of the p16INK4a tumor suppressor is associated with loss of CTCF binding and a chromatin boundary","volume":"34","author":"Witcher","year":"2009","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib102","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/MCB.23.1.206-215.2003","article-title":"Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer","volume":"23","author":"Kondo","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/epi.09.33","article-title":"DNA hypomethylation in cancer cells","volume":"1","author":"Ehrlich","year":"2009","journal-title":"Epigenomics"},{"key":"10.1016\/j.gendis.2022.12.013_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.589929","article-title":"TERT-regulation and roles in cancer formation","volume":"11","author":"Dratwa","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib105","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/14789450.2.5.719","article-title":"Histone structure and nucleosome stability","volume":"2","author":"Mari\u00f1o-Ram\u00edrez","year":"2005","journal-title":"Expert Rev Proteomics"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib106","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019521","article-title":"Histone modifications and cancer","volume":"8","author":"Audia","year":"2016","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib107","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrm2621","article-title":"MicroRNAs: key regulators of stem cells","volume":"10","author":"Gangaraju","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib108","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1158\/0008-5472.CAN-06-4218","article-title":"Genetic unmasking of an epigenetically silenced microRNA in human cancer cells","volume":"67","author":"Lujambio","year":"2007","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.gendis.2022.12.013_bib109","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/ijc.24638","article-title":"Epigenetic regulation of microRNA expression in colorectal cancer","volume":"125","author":"Bandres","year":"2009","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/cancers13030376","article-title":"Cancer stem cells-key players in tumor relapse","volume":"13","author":"Marzagalli","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2022.12.013_bib111","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41392-020-00313-5","article-title":"Emerging role of tumor cell plasticity in modifying therapeutic response","volume":"5","author":"Qin","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib112","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2011.01.020","article-title":"Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth","volume":"19","author":"Quante","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gendis.2022.12.013_bib113","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","article-title":"Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology","volume":"9","author":"Semenza","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib114","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbamcr.2015.05.036","article-title":"The hypoxic tumor microenvironment: a driving force for breast cancer progression","volume":"1863","author":"Semenza","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.gendis.2022.12.013_bib115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2012.11.010","article-title":"Aldehyde dehydrogenases in cellular responses to oxidative\/electrophilic stress","volume":"56","author":"Singh","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"10.1016\/j.gendis.2022.12.013_bib116","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/ijc.26311","article-title":"Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?","volume":"129","author":"Scheel","year":"2011","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm7010001","article-title":"Epithelial mesenchymal transition in embryonic development, tissue repair and cancer: a comprehensive overview","volume":"7","author":"Kim","year":"2018","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.gendis.2022.12.013_bib118","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/cancers13061469","article-title":"The epithelial-mesenchymal transcription factor SNAI1 represses transcription of the tumor suppressor miRNA let-7 in cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.gendis.2022.12.013_bib119","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3748\/wjg.v18.i7.601","article-title":"Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon","volume":"18","author":"Sipos","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/cancers11050692","article-title":"Role of integrins in resistance to therapies targeting growth factor receptors in cancer","volume":"11","author":"Cruz da Silva","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib121","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4161\/cbt.4.4.1655","article-title":"The epithelial-mesenchymal transition (EMT) and colorectal cancer progression","volume":"4","author":"Bates","year":"2005","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib122","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/bcr1524","article-title":"Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells","volume":"8","author":"Galliher","year":"2006","journal-title":"Breast Cancer Res"},{"issue":"25","key":"10.1016\/j.gendis.2022.12.013_bib123","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.1073\/pnas.0904227106","article-title":"Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs","volume":"106","author":"Shibue","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.gendis.2022.12.013_bib124","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2174\/187152012803833008","article-title":"Chemoprevention of breast cancer by dietary compounds","volume":"12","author":"Vadodkar","year":"2012","journal-title":"Anti Cancer Agents Med Chem"},{"issue":"8","key":"10.1016\/j.gendis.2022.12.013_bib125","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1634\/theoncologist.2011-0450","article-title":"The utility of hedgehog signaling pathway inhibition for cancer","volume":"17","author":"Sahebjam","year":"2012","journal-title":"Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0253-7613.124884","article-title":"Hedgehog signaling pathway: a novel target for cancer therapy: vismodegib, a promising therapeutic option in treatment of basal cell carcinomas","volume":"46","author":"Abidi","year":"2014","journal-title":"Indian J Pharmacol"},{"issue":"9","key":"10.1016\/j.gendis.2022.12.013_bib127","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.5966\/sctm.2015-0048","article-title":"Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target","volume":"4","author":"Yan","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.gendis.2022.12.013_bib128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2014.11.014","article-title":"Role of microRNAs in maintaining cancer stem cells","volume":"81","author":"Garofalo","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.gendis.2022.12.013_bib129","first-page":"831","article-title":"Characteristic and prognostic significance of leukemia stem cells associated antigens expressions in t (8;21) acute myeloid leukemia","volume":"40","author":"Dao","year":"2019","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib130","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.yexmp.2011.06.005","article-title":"Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to\u00a0chemotherapy outcome","volume":"91","author":"Luo","year":"2011","journal-title":"Exp Mol Pathol"},{"issue":"6","key":"10.1016\/j.gendis.2022.12.013_bib131","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/CJI.0000000000000086","article-title":"Targeting CD133high colorectal cancer cells in vitro and in vivo with an asymmetric bispecific antibody","volume":"38","author":"Zhao","year":"2015","journal-title":"J Immunother"},{"issue":"8","key":"10.1016\/j.gendis.2022.12.013_bib132","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.18632\/oncotarget.3462","article-title":"CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition","volume":"6","author":"Long","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019329","article-title":"The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1\/P-glycoprotein transporter","volume":"6","author":"Ding","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib134","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2217\/nnm.11.93","article-title":"P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells","volume":"7","author":"Navarro","year":"2012","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1245\/ASO.2005.03.093","article-title":"Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs","volume":"12","author":"Lans","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"10.1016\/j.gendis.2022.12.013_bib136","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4161\/cbt.8.15.9133","article-title":"Enhancing immune responses to tumor-associated antigens","volume":"8","author":"Higgins","year":"2009","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"10.1016\/j.gendis.2022.12.013_bib137","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s13238-017-0394-6","article-title":"Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment","volume":"9","author":"Guo","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.gendis.2022.12.013_bib138","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2162-3619-1-36","article-title":"CD19:a biomarker for B cell development, lymphoma diagnosis and therapy","volume":"1","author":"Wang","year":"2012","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.gendis.2022.12.013_bib139","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clim.2016.08.011","article-title":"Anti-CD20 antibody treatment of non-Hodgkin lymphomas","volume":"172","author":"Engelhard","year":"2016","journal-title":"Clin Immunol"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib140","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.gendis.2022.12.013_bib141","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.1182\/blood-2011-11-325050","article-title":"Acute myeloid leukemia stem cells and CD33-targeted immunotherapy","volume":"119","author":"Walter","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.gendis.2022.12.013_bib142","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1080\/10428194.2017.1285027","article-title":"Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia","volume":"58","author":"Vojdeman","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.gendis.2022.12.013_bib143","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/cancers14092136","article-title":"Immunotherapy for HER2-positive breast cancer: clinical evidence and future perspectives","volume":"14","author":"Agostinetto","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2022.12.013_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.635007","article-title":"Immunotherapy in treating EGFR-mutant lung cancer: current challenges and new strategies","volume":"11","author":"To","year":"2021","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib145","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/cancers13051031","article-title":"Angiogenesis inhibitors for colorectal cancer. a review of the clinical data","volume":"13","author":"Hansen","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2022.12.013_bib146","unstructured":"Kankanala V.L., Mukkamalla S.K.R.Carcinoembryonic Antigen. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022."},{"issue":"28","key":"10.1016\/j.gendis.2022.12.013_bib147","doi-asserted-by":"crossref","first-page":"24947","DOI":"10.18632\/oncotarget.4453","article-title":"An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer","volume":"6","author":"Liao","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib148","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3892\/ijo.2016.3371","article-title":"Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil","volume":"48","author":"Wang","year":"2016","journal-title":"Int J Oncol"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib149","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/bcr2636","article-title":"Targeting breast cancer stem cells: fishing season open","volume":"12","author":"Ginestier","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4155\/fmc.13.17","article-title":"Hypoxia inducible factor pathway inhibitors as anticancer therapeutics","volume":"5","author":"Burroughs","year":"2013","journal-title":"Future Med Chem"},{"issue":"Suppl 1","key":"10.1016\/j.gendis.2022.12.013_bib151","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3816\/CLC.2009.s.002","article-title":"Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer","volume":"10","author":"Horn","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.gendis.2022.12.013_bib152","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct Targeted Ther"},{"issue":"6","key":"10.1016\/j.gendis.2022.12.013_bib153","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.biomaterials.2011.11.029","article-title":"Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells","volume":"33","author":"Zhou","year":"2012","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib154","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/bc300632w","article-title":"Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors","volume":"24","author":"Wei","year":"2013","journal-title":"Bioconjugate Chem"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib155","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.3390\/pharmaceutics13122116","article-title":"Nanoparticle-based RNAi therapeutics targeting cancer stem cells: update and prospective","volume":"13","author":"Tang","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e05948","article-title":"Drug combination and repurposing for cancer therapy: the example of breast cancer","volume":"7","author":"Correia","year":"2021","journal-title":"Heliyon"},{"issue":"23","key":"10.1016\/j.gendis.2022.12.013_bib157","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.gendis.2022.12.013_bib158","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1166\/jbn.2016.2234","article-title":"Simultaneous targeting of differentiated breast cancer cells and breast cancer stem cells by combination of docetaxel- and sulforaphane-loaded self-assembled poly(D, L-lactide-co-glycolide)\/hyaluronic acid block copolymer-based nanoparticles","volume":"12","author":"Huang","year":"2016","journal-title":"J Biomed Nanotechnol"},{"issue":"6","key":"10.1016\/j.gendis.2022.12.013_bib159","first-page":"270","article-title":"Reports of the demise of chemotherapy have been greatly exaggerated","volume":"25","author":"Feinberg","year":"2019","journal-title":"Am J Manag Care"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand\u00a0challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib161","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.molonc.2012.02.004","article-title":"Discovery of small molecule cancer drugs: successes, challenges and opportunities","volume":"6","author":"Hoelder","year":"2012","journal-title":"Mol Oncol"},{"issue":"10","key":"10.1016\/j.gendis.2022.12.013_bib162","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.mayocp.2012.07.007","article-title":"The high cost of cancer drugs and what we can do about it","volume":"87","author":"Siddiqui","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib163","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: new estimates of drug development costs","volume":"22","author":"DiMasi","year":"2003","journal-title":"J Health Econ"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib164","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bph.13798","article-title":"Drug repurposing from the perspective of pharmaceutical companies","volume":"175","author":"Cha","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.gendis.2022.12.013_bib165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.semcancer.2019.09.012","article-title":"Drug repurposing for breast cancer therapy: old weapon for new battle","volume":"68","author":"Aggarwal","year":"2021","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib166","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3810\/pgm.2011.09.2475","article-title":"Key concepts of clinical trials: a narrative review","volume":"123","author":"Umscheid","year":"2011","journal-title":"Postgrad Med"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib167","first-page":"e115","article-title":"Drug development: the journey of a medicine from lab to shelf","volume":"9","author":"Omejc","year":"2020","journal-title":"J Dev Drugs"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib168","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1017\/S0963180115000079","article-title":"The flaws and human harms of animal experimentation","volume":"24","author":"Akhtar","year":"2015","journal-title":"Camb Q Healthc Ethics"},{"key":"10.1016\/j.gendis.2022.12.013_bib169","doi-asserted-by":"crossref","DOI":"10.3402\/gha.v7.25484","article-title":"Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs","volume":"7","author":"Chilet-Rosell","year":"2014","journal-title":"Glob Health Action"},{"issue":"6","key":"10.1016\/j.gendis.2022.12.013_bib170","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood-2006-01-010645","article-title":"Antithrombotic properties of aspirin and resistance to aspirin: beyond\u00a0strictly\u00a0antiplatelet actions","volume":"109","author":"Undas","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib171","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(05)67321-1","article-title":"Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo","volume":"164","author":"Liu","year":"2000","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19:results of an open label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib173","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","volume":"2014","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gendis.2022.12.013_bib174","article-title":"Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review","volume":"7","author":"Acharya","year":"2020","journal-title":"Ther Adv Infect Dis"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.encep.2020.05.006","article-title":"Repurposing chlorpromazine to treat COVID-19: the recovery study","volume":"46","author":"Plaze","year":"2020","journal-title":"L\u2019Enc\u00e9phale"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261358","article-title":"Colchicine use in patients with COVID-19: a systematic review and meta-analysis","volume":"16","author":"Chiu","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib177","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/bmb\/ldaa045","article-title":"Repurposing approved drugs for cancer therapy","volume":"137","author":"Schein","year":"2021","journal-title":"Br Med Bull"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib178","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/ph15050497","article-title":"Repurposing dimethyl fumarate for cardiovascular diseases: pharmacological effects, molecular mechanisms, and therapeutic promise","volume":"15","author":"Thomas","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"23","key":"10.1016\/j.gendis.2022.12.013_bib179","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM199506083322301","article-title":"Fluoxetine in the treatment of premenstrual Dysphoria. Canadian fluoxetine\/premenstrual Dysphoria collaborative study group","volume":"332","author":"Steiner","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gendis.2022.12.013_bib180","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: a review","volume":"13","author":"Suchonwanit","year":"2019","journal-title":"Drug Des Dev Ther"},{"issue":"19","key":"10.1016\/j.gendis.2022.12.013_bib181","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gendis.2022.12.013_bib182","series-title":"Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications [Internet]","article-title":"Drug repurposing (DR): an emerging approach in drug discovery","author":"Rudrapal","year":"2020"},{"key":"10.1016\/j.gendis.2022.12.013_bib183","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12885-018-4197-9","article-title":"Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial","volume":"18(1)","author":"Burock","year":"2018","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.gendis.2022.12.013_bib184","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1164\/rccm.201207-1180OC","article-title":"Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer","volume":"186","author":"Yeh","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib185","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/molecules25010224","article-title":"Chelerythrine chloride downregulates \u03b2-catenin and inhibits stem cell properties of non-small cell lung carcinoma","volume":"25","author":"Heng","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib186","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2022.12.013_bib187","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13027-017-0128-7","article-title":"The effects of antiviral treatment on breast cancer cell line","volume":"12","author":"Shaimerdenova","year":"2017","journal-title":"Infect Agent Cancer"},{"issue":"17","key":"10.1016\/j.gendis.2022.12.013_bib188","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/j.ejca.2012.04.013","article-title":"All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt\/\u03b2-catenin pathway","volume":"48","author":"Lim","year":"2012","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib189","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.18632\/oncotarget.23192","article-title":"Src is the primary target of aripiprazole, an atypical antipsychotic drug, in its anti-tumor action","volume":"9","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gendis.2022.12.013_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107706","article-title":"Artemisinins as a novel anti-cancer therapy: targeting a global cancer pandemic through drug repurposing","volume":"216","author":"Augustin","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.gendis.2022.12.013_bib191","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.2147\/DDDT.S264122","article-title":"Novel molecular mechanism of aspirin and celecoxib targeting mammalian neuraminidase-1 impedes epidermal growth factor receptor signaling axis and induces apoptosis in pancreatic cancer cells","volume":"14","author":"Qorri","year":"2020","journal-title":"Drug Des Dev Ther"},{"issue":"6","key":"10.1016\/j.gendis.2022.12.013_bib192","first-page":"8454","article-title":"Effects of aspirin on proliferation, invasion and apoptosis of Hep-2 cells via the PTEN\/AKT\/NF-\u03baB\/survivin signaling pathway","volume":"15","author":"Jin","year":"2018","journal-title":"Oncol Lett"},{"issue":"37","key":"10.1016\/j.gendis.2022.12.013_bib193","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.18632\/oncotarget.26949","article-title":"In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile","volume":"10","author":"Suzuki","year":"2019","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.gendis.2022.12.013_bib194","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in pancreatic cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2022.12.013_bib195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3332\/ecancer.2014.485","article-title":"Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent","volume":"8","author":"Pantziarka","year":"2014","journal-title":"Ecancermedicalscience"},{"issue":"13","key":"10.1016\/j.gendis.2022.12.013_bib196","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.3390\/cancers13133193","article-title":"Repurposing of antimicrobial agents for cancer therapy: what do we know?","volume":"13","author":"Pfab","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.gendis.2022.12.013_bib197","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/stem.1746","article-title":"Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1","volume":"32","author":"Choi","year":"2014","journal-title":"Stem Cell"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib198","first-page":"599","article-title":"Curcumin and cancer stem cells: curcumin has asymmetrical effects on cancer and normal stem cells","volume":"35","author":"Sordillo","year":"2015","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib199","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.taap.2006.12.011","article-title":"Novel Hedgehog pathway targets against basal cell carcinoma","volume":"224","author":"Tang","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.gendis.2022.12.013_bib200","first-page":"610","article-title":"Repurposing drugs in oncology (ReDO)-diclofenac as an anti-cancer agent","volume":"10","author":"Pantziarka","year":"2016","journal-title":"Ecancermedicalscience"},{"issue":"38","key":"10.1016\/j.gendis.2022.12.013_bib201","doi-asserted-by":"crossref","first-page":"40907","DOI":"10.18632\/oncotarget.5723","article-title":"Disulfiram inhibits TGF-\u03b2-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK\/NF-\u03baB\/Snail pathway","volume":"6","author":"Han","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.gendis.2022.12.013_bib202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/15384101.2016.1241929","article-title":"Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer","volume":"16","author":"Zhang","year":"2017","journal-title":"Cell Cycle"},{"issue":"13","key":"10.1016\/j.gendis.2022.12.013_bib203","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.18632\/oncotarget.7567","article-title":"Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer","volume":"7","author":"Toden","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib204","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2012.03.037","article-title":"Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway","volume":"323","author":"Zhang","year":"2012","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2012.01.045","article-title":"Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells","volume":"321","author":"Mai","year":"2012","journal-title":"Cancer Lett"},{"issue":"16","key":"10.1016\/j.gendis.2022.12.013_bib206","doi-asserted-by":"crossref","first-page":"21875","DOI":"10.18632\/oncotarget.7871","article-title":"The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells","volume":"7","author":"Ruiz-Maga\u00f1a","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib207","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1947601910365081","article-title":"DNA demethylating antineoplastic strategies: a comparative point of view","volume":"1","author":"Amatori","year":"2010","journal-title":"Genes Cancer"},{"issue":"8","key":"10.1016\/j.gendis.2022.12.013_bib208","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/cbin.10959","article-title":"Ibuprofen reduces cell proliferation through inhibiting Wnt\/\u03b2 catenin signaling pathway in gastric cancer stem cells","volume":"42","author":"Akrami","year":"2018","journal-title":"Cell Biol Int"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib209","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ijc.28381","article-title":"Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH\/HES1 and activating PPARG in colorectal cancer","volume":"134","author":"Moon","year":"2014","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib210","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3892\/ol.2017.6325","article-title":"Repurposing itraconazole as an anticancer agent","volume":"14","author":"Tsubamoto","year":"2017","journal-title":"Oncol Lett"},{"issue":"9","key":"10.1016\/j.gendis.2022.12.013_bib211","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3390\/cancers11091284","article-title":"Mebendazole as a candidate for drug repurposing in oncology: an extensive review of current literature","volume":"11","author":"Guerini","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2022.12.013_bib212","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/980458","article-title":"Colorectal cancer chemoprevention by mesalazine and its derivatives","volume":"2012","author":"Stolfi","year":"2012","journal-title":"J Biomed Biotechnol"},{"issue":"19","key":"10.1016\/j.gendis.2022.12.013_bib213","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.gendis.2022.12.013_bib214","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070010","article-title":"Metformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cells","volume":"8","author":"Saito","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gendis.2022.12.013_bib215","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9290728","article-title":"Metformin suppresses self-renewal ability and tumorigenicity of osteosarcoma stem cells via reactive oxygen species-mediated apoptosis and autophagy","volume":"2019","author":"Zhao","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"A","key":"10.1016\/j.gendis.2022.12.013_bib216","first-page":"25","article-title":"Thiazolidinediones as anti-cancer agents","volume":"6","author":"Blanquicett","year":"2008","journal-title":"Cancer Ther"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib217","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","article-title":"Multi-targeted therapy of cancer by niclosamide: a new application for an old drug","volume":"349","author":"Li","year":"2014","journal-title":"Cancer Lett"},{"issue":"9","key":"10.1016\/j.gendis.2022.12.013_bib218","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.5966\/sctm.2015-0054","article-title":"Drug transporter-mediated protection of cancer stem cells from ionophore antibiotics","volume":"4","author":"Boesch","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"45","key":"10.1016\/j.gendis.2022.12.013_bib219","doi-asserted-by":"crossref","first-page":"18226","DOI":"10.1073\/pnas.1317577110","article-title":"Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma","volume":"110","author":"Yuan","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib220","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10549-009-0612-x","article-title":"Targeting breast stem cells with the cancer preventive compounds curcumin and piperine","volume":"122","author":"Kakarala","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib221","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.biomaterials.2011.09.055","article-title":"Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.gendis.2022.12.013_bib222","first-page":"127","article-title":"Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women","volume":"3","author":"Vogel","year":"2011","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.gendis.2022.12.013_bib223","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12929-020-00679-2","article-title":"Amino acid-dependent control of mTORC1 signaling: a variety of regulatory modes","volume":"27","author":"Takahara","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.gendis.2022.12.013_bib224","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"issue":"23","key":"10.1016\/j.gendis.2022.12.013_bib225","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1182\/blood.V126.23.5351.5351","article-title":"Targeting cancer stem cell survival in plasma cell leukemia with a pan-BCL2 inhibitor","volume":"126","author":"Elisa","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.gendis.2022.12.013_bib226","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cbi.2014.12.002","article-title":"Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling","volume":"228","author":"Lu","year":"2015","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib227","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7150\/jca.34847","article-title":"The antipsychotic agent sertindole exhibited antiproliferative activities by inhibiting the STAT3 signaling pathway in human gastric cancer cells","volume":"11","author":"Dai","year":"2020","journal-title":"J Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib228","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-009-9929-x","article-title":"Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells","volume":"95","author":"Ohba","year":"2009","journal-title":"J Neuro Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib229","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/carcin\/bgr317","article-title":"Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like\/progenitor cells","volume":"33","author":"Montales","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.gendis.2022.12.013_bib230","article-title":"Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124\/IL-6R\/STAT3 axis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib231","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.77","article-title":"Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data","volume":"6","author":"Cheng","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gendis.2022.12.013_bib232","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.713040","article-title":"Editorial: repurposed drugs targeting cancer signaling pathways: clinical insights to improve oncologic therapies","volume":"11","author":"P\u00e9rez-Plasencia","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.gendis.2022.12.013_bib233","year":"2022","journal-title":"Anticancerfund.org."},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib234","first-page":"84","article-title":"Cancer therapy with phytochemicals: evidence from clinical studies","volume":"5","author":"Hosseini","year":"2015","journal-title":"Avicenna J Phytomed"},{"key":"10.1016\/j.gendis.2022.12.013_bib235","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.639628","article-title":"Phytochemicals as a complement to cancer chemotherapy: pharmacological modulation of the autophagy-apoptosis pathway","volume":"12","author":"Rahman","year":"2021","journal-title":"Front Pharmacol"},{"issue":"20","key":"10.1016\/j.gendis.2022.12.013_bib236","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.3390\/ijms20204981","article-title":"Role of phytochemicals in cancer prevention","volume":"20","author":"Ranjan","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"3 Suppl","key":"10.1016\/j.gendis.2022.12.013_bib237","doi-asserted-by":"crossref","first-page":"816S","DOI":"10.1093\/jn\/136.3.816S","article-title":"Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer","volume":"136","author":"Ishikawa","year":"2006","journal-title":"J Nutr"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib238","first-page":"1423","article-title":"Piperlongumine induces apoptosis and autophagy in leukemic cells through targeting the PI3K\/Akt\/mTOR and p38 signaling pathways","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol Lett"},{"issue":"13","key":"10.1016\/j.gendis.2022.12.013_bib239","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.18632\/oncotarget.3427","article-title":"Inhibition of \u03b2-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear \u03b2-catenin\/TCF-1 complex: critical role of STAT-3","volume":"6","author":"Pramanik","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.gendis.2022.12.013_bib240","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.908487","article-title":"Capsaicin: a two-decade systematic review of global research output and recent advances against human cancer","volume":"12","author":"Adetunji","year":"2022","journal-title":"Front Oncol"},{"issue":"22","key":"10.1016\/j.gendis.2022.12.013_bib241","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212455","article-title":"Targeting PI3K\/Akt\/mTOR pathway by different flavonoids: a cancer\u00a0chemopreventive approach","volume":"22","author":"Zughaibi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2022.12.013_bib242","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.906746","article-title":"Green tea epigallocatechin-3-gallate regulates autophagy in male and female reproductive cancer","volume":"13","author":"Hung","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2022.12.013_bib243","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.synres.2015.04.001","article-title":"Combined effect of paclitaxel and piperine on a MCF-7 breast cancer cell line in vitro: evidence of a synergistic interaction","volume":"2","author":"Motiwala","year":"2015","journal-title":"Synergy"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib244","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17727\/JMSR.2014\/2-012","article-title":"Enhancement of paclitaxel and doxorubicin cytotoxicity in breast cancer cell lines in combination with piperine treatment and analysis of expression of autophagy and apoptosis genes","volume":"2","author":"Pushpa Ragini","year":"2014","journal-title":"J Med Sci Res"},{"issue":"3","key":"10.1016\/j.gendis.2022.12.013_bib245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193918","article-title":"Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model","volume":"13","author":"Bose","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib246","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1007\/s13277-015-4307-0","article-title":"The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer","volume":"37","author":"\u015eakalar","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1016\/j.gendis.2022.12.013_bib247","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30046-z","article-title":"Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities","volume":"8","author":"Bashmail","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.gendis.2022.12.013_bib248","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/cancers2020859","article-title":"Role of oxidative stress in stem, cancer, and cancer stem cells","volume":"2","author":"Dayem","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2022.12.013_bib249","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3389\/fonc.2019.01104","article-title":"Therapeutic strategies targeting cancer stem cells and their microenvironment","volume":"9","author":"Sun","year":"2019","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.gendis.2022.12.013_bib250","doi-asserted-by":"crossref","first-page":"712","DOI":"10.5306\/wjco.v12.i9.712","article-title":"Embracing cancer immunotherapy with\u00a0vital micronutrients","volume":"12","author":"Yuen","year":"2021","journal-title":"World J Clin Oncol"},{"issue":"10","key":"10.1016\/j.gendis.2022.12.013_bib251","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.4161\/cbt.7.10.6573","article-title":"Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma","volume":"7","author":"Kast","year":"2008","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"10.1016\/j.gendis.2022.12.013_bib252","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3390\/cancers11121915","article-title":"Retinoic acid receptors in acute myeloid leukemia therapy","volume":"11","author":"Martino","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.gendis.2022.12.013_bib253","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jnci\/91.6.535","article-title":"Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers","volume":"91","author":"Stolzenberg-Solomon","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib254","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/(SICI)1097-0215(19981109)78:4<415::AID-IJC4>3.0.CO;2-X","article-title":"Nutrient intake patterns and gastric cancer risk: a case-control study in Belgium","volume":"78","author":"Kaaks","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gendis.2022.12.013_bib255","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<122::AID-IJC19>3.0.CO;2-2","article-title":"Selected micronutrients and oral and pharyngeal cancer","volume":"86","author":"Negri","year":"2000","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.gendis.2022.12.013_bib256","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/aje\/153.7.688","article-title":"Association of the B-vitamins pyridoxal 5'-phosphate (B6), B12, and folate with lung cancer risk in older men","volume":"153","author":"Hartman","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.gendis.2022.12.013_bib257","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/bjc.1997.445","article-title":"A case-control study\u00a0of\u00a0diet and prostate cancer","volume":"76","author":"Key","year":"1997","journal-title":"Br J Cancer"},{"issue":"20","key":"10.1016\/j.gendis.2022.12.013_bib258","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4161\/cc.8.20.9761","article-title":"Retinoid signaling regulates breast cancer stem cell differentiation","volume":"8","author":"Ginestier","year":"2009","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.gendis.2022.12.013_bib259","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0959-8049(95)00059-R","article-title":"Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines","volume":"31","author":"De Laurenzi","year":"1995","journal-title":"Eur J Cancer"},{"issue":"40","key":"10.1016\/j.gendis.2022.12.013_bib260","doi-asserted-by":"crossref","first-page":"67269","DOI":"10.18632\/oncotarget.18428","article-title":"Vitamin C and Doxycycline: a synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)","volume":"8","author":"De Francesco","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gendis.2022.12.013_bib261","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jsbmb.2014.10.007","article-title":"Targeting cancer stem cells in solid tumors by vitamin D","volume":"148","author":"So","year":"2015","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304223000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304223000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:19:44Z","timestamp":1778872784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304223000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":261,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2352304223000089"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2022.12.013","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2022.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}